Insiders Vor Biopharma Inc.

Equities

VOR

US9290331084

Delayed Nasdaq Other stock markets 12:38:35 28/06/2024 am IST			5-day change	1st Jan Change
1.15 ^USD	0.00%		-5.00%	-49.33%

13/06	Voyager Therapeutics Names Nathan Jorgensen as Finance Chief	MT
10/06	Vor Biopharma Inc. Announces Management Appointments, Effective June 21, 2024	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Voyager Therapeutics Names Nathan Jorgensen as Finance Chief	13/06	MT
Vor Biopharma Inc. Announces Management Appointments, Effective June 21, 2024	11/06	CI
Nathan Jorgensen Resigns as Chief Financial Officer of Vor Biopharma Inc., Effective June 21, 2024	11/06	CI
Vor Biopharma Inc. Appoints Fouad Namouni as Class II Director	03/05	CI
Vor Biopharma Inc. Announces Resignation of Kush Parmar, Member of the Board of Directors	15/23/15	CI
Vor Bio Appoints Eyal C. Attar, M.D. as Chief Medical Officer	12/22/12	CI
Vor Biopharma Chief Medical Officer Christopher Slapak to Retire	15/22/15	MT
Vor Biopharma Inc. Announces Retirement of Christopher Slapak as Chief Medical Officer	15/22/15	CI
Insider Sell: Vor Biopharma	19/21/19	MT
Vor Biopharma Announces the Appointment of Veit Schmelmer as Senior Vice President of Program and Alliance Management	12/21/12	CI
Vor Biopharma Announces Management Changes	11/21/11	CI
Vor Biopharma Promotes Tirtha Chakraborty to Chief Scientific Officer	19/20/19	CI
Vor Biopharma Appoints Matthew Patterson to Its Board of Directors	06/20/06	CI
Vor Biopharma, Inc. Appoints Matthew R Patterson to Its Board of Directors	20/20/20	CI
Vor Biopharma Appoints John King as Chief Commercial Officer	08/20/08	CI
Vor Biopharma, Appoints John King as Chief Commercial Officer	26/20/26	CI
Vor Biopharma Appoints David Lubner to its Board of Directors	30/20/30	CI
Vor Biopharma Appoints Daniella Beckman to Board of Directors	16/20/16	CI
Vor Biopharma Appoints Christopher Slapak as Chief Medical Officer	14/20/14	CI
Vor Biopharma, Inc. Announces Appointment of Nathan Jorgensen as Chief Financial Officer	26/20/26	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Vor Biopharma Inc.

Equities

VOR

US9290331084

Insiders

Filters